HIV/AIDS Therapy

Survey shows adherence to HIV treatment regimens high but meaning not understood

Published in Vaccine Weekly, November 23rd, 2005

Results have been released from one of the largest national surveys on medication adherence issues for people living with HIV/AIDS which show adherence to HIV treatment regimens as prescribed is high, but misconceptions about what proper adherence means still remains.

The survey was conducted by Richard Day Research (RDR) and underwritten by Bristol-Myers Squibb Company (BMY).

The 403 Internet-survey respondents had an average of 8 years experience taking anti-HIV medications, and 85% reported they understood how to take their medications properly with 69% reporting complete adherence (>95%) to their regimens. While 12% felt that taking their...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2005-11-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry